Perilous journey: A tour of the ubiquitin-proteasome system

Trends in Cell Biology

Volumn 24, Issue 6, 2014, Pages 352-359

  Kleiger, Gary ^a   Mayor, Thibault ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

E1 activating; E2 conjugating; E3 ligase; Proteolysis; Ubiquitin proteasome system

Indexed keywords

DNA 26S; PROTEASOME; PROTEINASE; UBIQUITIN CONJUGATING ENZYME E1; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E3; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

CATALYSIS; CELL FUNCTION; CONJUGATION; EUKARYOTIC CELL; HUMAN; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REVIEW; UBIQUITIN PROTEASOME SYSTEM; UBIQUITINATION; ANIMAL; METABOLISM;

EUKARYOTA;

ANIMALS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84901466274     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.12.003     Document Type: Review

References (88)

1. Deshaies R.J., Joazeiro C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78:399-434.
2. Xu P., et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009, 137:133-145.
3. Tokunaga F., et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol. 2009, 11:123-132.
4. Komander D., Rape M. The ubiquitin code. Annu. Rev. Biochem. 2012, 81:203-229.
5. Schulman B.A., Harper J.W. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 2009, 10:319-331.
6. Yang Y., et al. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 2007, 67:9472-9481.
7. Huang D.T., et al. Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity. Nature 2007, 445:394-398.
8. Olsen S.K., et al. Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature 2010, 463:906-912.
9. Olsen S.K., Lima C.D. Structure of a ubiquitin E1-E2 complex: insights to E1-E2 thioester transfer. Mol. Cell 2013, 49:884-896.
10. Lake M.W., et al. Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex. Nature 2001, 414:325-329.
11. Lee I., Schindelin H. Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes. Cell 2008, 134:268-278.
12. Lois L.M., Lima C.D. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J. 2005, 24:439-451.
13. Walden H., et al. The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. Mol. Cell 2003, 12:1427-1437.
14. Huang D.T., et al. E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol. Cell 2009, 33:483-495.
15. Tokgoz Z., et al. E1-E2 interactions in ubiquitin and Nedd8 ligation pathways. J. Biol. Chem. 2012, 287:311-321.
16. Soucy T.A., et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009, 458:732-736.
17. Ohta T., et al. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 1999, 3:535-541.
18. Tan P., et al. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol. Cell 1999, 3:527-533.
19. Dou H., et al. BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat. Struct. Mol. Biol. 2012, 19:876-883.
20. Pruneda J.N., et al. Structure of an E3:E2~Ub complex reveals an allosteric mechanism shared among RING/U-box ligases. Mol. Cell 2012, 47:933-942.
21. Plechanovova A., et al. Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature 2012, 489:115-120.
22. Hamilton K.S., et al. Structure of a conjugating enzyme-ubiquitin thiolester intermediate reveals a novel role for the ubiquitin tail. Structure 2001, 9:897-904.
23. Saha A., et al. Essential role for ubiquitin-ubiquitin-conjugating enzyme interaction in ubiquitin discharge from Cdc34 to substrate. Mol. Cell 2011, 42:75-83.
24. Wickliffe K.E., et al. The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 2011, 144:769-781.
25. Pruneda J.N., et al. Ubiquitin in motion: structural studies of the ubiquitin-conjugating enzyme approximately ubiquitin conjugate. Biochemistry 2011, 50:1624-1633.
26. Dou H., et al. Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat. Struct. Mol. Biol. 2013, 20:982-986.
27. Kamadurai H.B., et al. Mechanism of ubiquitin ligation and lysine prioritization by a HECT E3. eLife 2013, 2:e00828.
28. Kamadurai H.B., et al. Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol. Cell 2009, 36:1095-1102.
29. Verdecia M.A., et al. Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. Mol. Cell 2003, 11:249-259.
30. Huang L., et al. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 1999, 286:1321-1326.
31. Maspero E., et al. Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. Nat. Struct. Mol. Biol. 2013, 20:696-701.
32. Ogunjimi A.A., et al. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol. Cell 2005, 19:297-308.
33. Riley B.E., et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat. Commun. 2013, 4:1982.
34. Trempe J.F., et al. Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 2013, 340:1451-1455.
35. Wenzel D.M., et al. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 2011, 474:105-108.
36. Spratt D.E., et al. A molecular explanation for the recessive nature of parkin-linked Parkinson's disease. Nat. Commun. 2013, 4:1983.
37. Duda D.M., et al. Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism. Structure 2013, 21:1030-1041.
38. Kleiger G., et al. The acidic tail of the Cdc34 ubiquitin-conjugating enzyme functions in both binding to and catalysis with ubiquitin ligase SCFCdc4. J. Biol. Chem. 2009, 284:36012-36023.
39. Yew P.R., Kirschner M.W. Proteolysis and DNA replication: the CDC34 requirement in the Xenopus egg cell cycle. Science 1997, 277:1672-1676.
40. Thrower J.S., et al. Recognition of the polyubiquitin proteolytic signal. EMBO J. 2000, 19:94-102.
41. Chau V., et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989, 243:1576-1583.
42. Pierce N.W., et al. Detection of sequential polyubiquitylation on a millisecond timescale. Nature 2009, 462:615-619.
43. Evans T., et al. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 1983, 33:389-396.
44. Kim W., et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 2011, 44:325-340.
45. Mayor T., et al. Quantitative profiling of ubiquitylated proteins reveals proteasome substrates and the substrate repertoire influenced by the Rpn10 receptor pathway. Mol. Cell. Proteomics 2007, 6:1885-1895.
46. Comyn S.A., et al. False start: cotranslational protein ubiquitination and cytosolic protein quality control. J. Proteomics 2013, 10.1016/j.jprot.2013.08.005.
47. Brodsky J.L. Cleaning up: ER-associated degradation to the rescue. Cell 2013, 151:1163-1167.
48. Schubert U., et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
49. Wang F., et al. A cotranslational ubiquitination pathway for quality control of misfolded proteins. Mol. Cell 2013, 50:368-378.
50. Duttler S., et al. Principles of cotranslational ubiquitination and quality control at the ribosome. Mol. Cell 2013, 50:379-393.
51. Turner G.C., Varshavsky A. Detecting and measuring cotranslational protein degradation in vivo. Science 2000, 289:2117-2120.
52. Dantuma N.P., Hoppe T. Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin. Trends Cell Biol. 2012, 22:483-491.
53. Defenouillere Q., et al. Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5046-5051.
54. Verma R., et al. Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome. eLife 2013, 2:e00308.
55. Brandman O., et al. A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 2012, 151:1042-1054.
56. Xu Y., et al. SGTA recognizes a noncanonical ubiquitin-like domain in the Bag6-Ubl4A-Trc35 complex to promote endoplasmic reticulum-associated degradation. Cell Rep. 2012, 2:1633-1644.
57. Wang Q., et al. A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation. Mol. Cell 2011, 42:758-770.
58. Minami R., et al. BAG-6 is essential for selective elimination of defective proteasomal substrates. J. Cell Biol. 2010, 190:637-650.
59. Hessa T., et al. Protein targeting and degradation are coupled for elimination of mislocalized proteins. Nature 2011, 475:394-397.
60. Lehner B., et al. Analysis of a high-throughput yeast two-hybrid system and its use to predict the function of intracellular proteins encoded within the human MHC class III region. Genomics 2004, 83:153-167.
61. Guerrero C., et al. Characterization of the proteasome interaction network using a QTAX-based tag-team strategy and protein interaction network analysis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13333-13338.
62. Komander D., et al. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
63. Zhang Z.R., et al. Deubiquitinases sharpen substrate discrimination during membrane protein degradation from the ER. Cell 2013, 154:609-622.
64. D'Arcy P., et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat. Med. 2011, 17:1636-1640.
65. Lee B.H., et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 2010, 467:179-184.
66. Torres E.M., et al. Identification of aneuploidy-tolerating mutations. Cell 2010, 143:71-83.
67. Verma R., et al. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 2010, 118:99-110.
68. Elsasser S., et al. Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J. Biol. Chem. 2004, 279:26817-26822.
69. Husnjak K., et al. Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 2008, 453:481-488.
70. van Nocker S., et al. The multiubiquitin-chain-binding protein Mcb1 is a component of the 26S proteasome in Saccharomyces cerevisiae and plays a nonessential, substrate-specific role in protein turnover. Mol. Cell. Biol. 1996, 16:6020-6028.
71. Yao T., Cohen R.E. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 2002, 419:403-407.
72. Verma R., et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002, 298:611-615.
73. Lander G.C., et al. Complete subunit architecture of the proteasome regulatory particle. Nature 2012, 482:186-191.
74. Beck F., et al. Near-atomic resolution structural model of the yeast 26S proteasome. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:14870-14875.
75. Matyskiela M.E., et al. Conformational switching of the 26S proteasome enables substrate degradation. Nat. Struct. Mol. Biol. 2013, 20:781-788.
76. Sledz P., et al. Structure of the 26S proteasome with ATP-gammaS bound provides insights into the mechanism of nucleotide-dependent substrate translocation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:7264-7269.
77. Hideshima T., et al. Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma. Mol. Cancer Ther. 2011, 10:2034-2042.
78. Dammer E.B., et al. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J. Biol. Chem. 2011, 286:10457-10465.
79. Jin L., et al. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 2008, 133:653-665.
80. Chastagner P., et al. Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains. EMBO Rep. 2006, 7:1147-1153.
81. Johnson E.S., et al. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 1995, 270:17442-17456.
82. Saeki Y., et al. Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J. 2009, 28:359-371.
83. Nathan J.A., et al. Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?. EMBO J. 2013, 32:552-565.
84. Jacobson A.D., et al. The lysine 48 and lysine 63 ubiquitin conjugates are processed differently by the 26 s proteasome. J. Biol. Chem. 2009, 284:35485-35494.
85. Wu P.Y., et al. A conserved catalytic residue in the ubiquitin-conjugating enzyme family. EMBO J. 2003, 22:5241-5250.
86. Berndsen C.E., et al. A conserved asparagine has a structural role in ubiquitin-conjugating enzymes. Nat. Chem. Biol. 2013, 9:154-156.
87. Yunus A.A., Lima C.D. Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway. Nat. Struct. Mol. Biol. 2006, 13:491-499.
88. Eddins M.J., et al. Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nat. Struct. Mol. Biol. 2006, 13:915-920.